Current Practice in the Treatment of Haemophilia

Abstract

Haematologists are long standing proponents of evidence based practice—well exemplified among professionals who care for patients with haemophilia. The rapidly expanding range of therapeutic products and the numerous accompanying clinical trials are swiftly interpreted and translated into clinical practice. This translation is formalised by frequently updated quidelines issued by the United Kingdom Haemophilia Centre Directors' Organisation (UKHCDO) and relevant to all doctors involved in the care of patients with haemophilia. In the last five years eight sets of guidelines have been issued in the UK alone relating to the treatment of haemophilia and its complications [1–8]. Against this background we aim to review current practice in the treatment of haemophilia.

Keywords:

• Haemophilia
• replacement therapy
• inhibitors
• gene therapy